A delayed class of BOLD waveforms associated with spreading depression in the feline cerebral cortex can be detected and characterised using independent component analysis (ICA)

Magnetic Resonance Imaging

Volumn 21, Issue 9, 2003, Pages 1097-1110

  Netsiri, Chaiyapoj ^a   Bradley, Daniel P ^a,b   Takeda, Tsunehiro ^c   Smith, Martin I ^d   Papadakis, Nikolas ^a   Hall, Laurance D ^b   Parsons, Andrew A ^d   James, Michael F ^d   Huang, Christopher L H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF TOKYO   (Japan)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Animal model; Headache; ICA; Migraine; Spreading depression

Indexed keywords

AGAR; ANTICONVULSIVE AGENT; ANTIMIGRAINE AGENT; POTASSIUM CHLORIDE; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SUMATRIPTAN; TONABERSAT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD OXYGENATION; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN REGION; CAT; CONTROLLED STUDY; HEADACHE; HEMISPHERE; INDEPENDENT COMPONENT ANALYSIS; MATHEMATICAL ANALYSIS; MIGRAINE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING; SPREADING CORTICAL DEPRESSION; SUPRASYLVIAN GYRUS; WAVEFORM;

ANIMALIA; FELIDAE; FELIS CATUS;

EID: 0348010229     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(03)00199-1     Document Type: Article

References (61)

1. Leão AAP. Spreading depression activity in the cerebral cortex. J Neurophysiol 1944;7:359-90.
2. Lashley KS. Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psych 1941;46:331-9.
3. Milner PM. Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão. EEG Clin Neurophy 1958;10:705.
4. Olesen J. Cerebral and extracranial circulatory disturbances in migraine. Pathophysiological implications. Cerebrovasc Metab Rev 1991;3:1-28.
5. Lauritzen M. Pathophysiology of migraine aura: The Spreading depression theory. Brain 1994;117:199-210.
6. James MF, Smith MI, Bockhorst KHJ, Hall LD, Houston GC, Papadakis NG, Smith JM, Williams EJ, Xing D, Parsons AA, Huang CL-H, Carpenter TA. Cortical spreading depression in the gyrencephalic feline brain studied by magnetic resonance imaging. J Physiol 1999;519(2):415-25.
7. Bockhorst KHJ, Smith JM, Smith MI, Bradley DP, Houston GC, Carpenter TA, Hall LD, Papadakis NG, Parsons AA, Huang CL-H, James MF. A quantitative analysis of cortical spreading depression events in the feline brain characterized with diffusion weighted MRI. J Magn Res Imag 2000;12:722-33.
8. Lauritzen M, Jørgensen MB, Diewer NH, Gjedde A, Hansen AJ. Resistent oligaemia of rat cerebral cortex in the wake of SD. Ann Neurol 1982;12:469-72.
9. Piper RD, Lambert GA, Duckworth JW. Cortical blood flow changes during spreading depression in cats. Am J Physiol 1991;261(1 Part 11):H96-H102.
10. Wahl M, Lauritzen M, Schilling L. Change of cerebrovascular reactivity after cortical spreading depression in cats and rats. Brain Res 1987;411:72-80.
11. de Crespigny A, Röther J, van Bruggen N, Beaulieu C, Moseley ME. Magnetic resonance imaging assessment of cerebral hemodynamics during spreading depression in rats. J Cereb Blood Flow Metabol 1998;18(9):1008-17.
12. Cutrer FM, Sorensen AG, Weiskoff RM. Perfusion weighted imaging defects during spontaneous migraine with aura. Ann Neurol 1998;43:25-31.
13. Functional neuroimaging: enhanced understanding of migraine pathophysiology. Neurol 2000.
14. Cao Y, Welch KMA, Aurora S, Vikingstad EM. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 1999;56(5):548-54.
15. Hadjikhani N, del Rio MS, Wu O, Schwartz D, Bakker D, Fischl B, Kwong KK, Cutrer FM, Rosen BR, Tootell RBH, Sorensen AG, Moskowitz MA. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proceed Natl Acad Sci USA 2001;98(8): 4687-92.
16. Biswal BB, Ulmer JL. Blind source separation of multiple signal sources of fMRI data sets using independent component analysis. J Comput Assist Tomograph 1999;23(2):265-71.
17. McKeown MJ, Makeig S, Brown GG, Jung TP, Kindermann SS, Bell AJ, Sejnowski TJ. Analysis of fMRI data by blind separation into independent spatial components. Hum Brain Mapp 1998;6(3):160-88.
18. Moritz CH, Haughton VM, Cordes D, Quigley M, Meyerand ME. Whole-brain functional MR imaging activation from a finger-tapping task examined with independent component analysis. Am J Neuroradiol 2000;21(9):1629-35.
19. de Crespigny AJ, Wendland MF, Derugin N, Kozniewska E, Moseley ME. Real-Time Observation of Transient Focal Ischemia and Hyperemia in Cat Brain. Magn Reson Med 1992;27(2):391-7.
20. Houston GC, Papadakis NG, Carpenter TA, Hall LD, Mukherjee B, James MF, Huang CLH. Mapping of the cerebral response to hypoxia measured using graded asymmetric spin echo EPI. Magn Reson Imag 2000;18(9):1043-54.
21. van Zijl OCM, Eleff SM, Ulatolwski JA, Oja JME, Ulug AM, Traystman RJ, Kauppinen RA. Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging. Nat Med 1998;4:159-67.
22. McKeown MJ, Sejnowski TJ. Independent component analysis of fMRI data: Examining the assumptions. Hum Brain Mapp 1998;6(5-6):368-72.
23. Brown GD, Yamada S, Sejnowski TJ. Independent component analysis at the neural cocktail party. Trends Neuro 2001;24(1):54-63.
24. Afrankis K, Cordes D, Haughton VM, Moritz CH, Quigley MA, Meyerand ME. Combining independent component analysis and correlation analysis to probe interregional connectivity in fMRI task activation datasets. Magn Reson Imag 2000;18:921-30.
25. Bradley DP, Smith MI, Smith JM, Bockhorst KHJ, Hall LD, Huang C-LH, Parsons AA, James MF. Inhibition of cortical spreading depression (CSD) initiation in the cat brain by Tonabersat, but not Sumatriptan, detected with diffusion-weighted magnetic resonance imaging (DWI). Exper Neurol 2001;172:342-53.
26. Stables LA, Kennan RP, Gore JC. Asymmetric spin-echo imaging of magnetically inhomogeneous systems: Theory, experiment, and numerical studies. Magn Reson Med 1998;40(3):432-42.
27. Lee T-W. Independent Component Analysis: Theory and Applications. Third ed. Boston: Kluwer Academic Publishers, 2001.
28. 2 response. J Cereb Blood Flow Metabol 1984;4:546-54.
29. Bureš J, Buresová O, Krivánek J. The mechanisms and applications of Leão's spreading depression of electroencephalagrapic activity; New York Academic Press, 1974.
30. Ebersberger A, Schaible HG, Averbeck B, Richter F. Is there a correlation between spreading depression, neurogenic inflammation, and nociception that might cause migraine headache? Ann Neurol 2001;49(1):7-13.
31. Kaube K, Goadsby PJ. Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat. Europe Neurol 1994;34:30-5.
32. Lauritzen M, Olesen J. Regional cerebral blood flow during migraine attacks by xenon-133 inhalation and emission tomography. Brain 1984;107:447-61.
33. Olessen J, Larsen B, Lauritzen M. Focal hyperaemia followed by spreading oligaemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-51.
34. Skinhoj E. Heamodynamic studies within the brain during migraine. Arch Neurol 1973;29:95-8.
35. Martins-Ferreira H, Nedergaard M, Nicholson C. Perspectives on spreading depression. Brain Res Rev 2000;32(1):215-34.
36. Gorji A. Spreading depression: a review of the clinical relevance. Brain Res Rev 2001;38(1-2):33-60.
37. Gorji A, Scheller D, Straub H, Tegtmeier F, Kohling R, Hohling JM, Tuxhorn I, Ebner A, Wolf P, Panneck HW, Oppel F, Speckmann EJ. Spreading depression in human neocortical slices. Brain Res 2001;906(1-2):74-83.
38. Read SJ, Smith MI, Hunter AJ, Upton N, Parsons AA. SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat. Cephalalgia 2000;20(2):92-9.
39. Read SJ, Smith MI, Chan WN, Thompson M, Hunter AJ, Parsons AA, Upton N. SB-220453 inhibits cortical spreading depression in the anaesthetised cat. Neurol 1999;52(52 6 S2):A275.
40. Kuge Y, Hasegawa Y, Yokota C, Minematsu K, Hashimoto N, Miyake Y, Yamaguchi T. Effects of single and repetitive spreading depression on cerebral blood flow and glucose metabolism in cats: a PET study. J Neurol Sci 2000;176:114-23.
41. Smith MI, Read SJ, Chan WN, Thompson M, Hunter AJ, Upton N, Parsons AA. Repetitive cortical spreading depression in a gyrencephalic feline brain: inhibition by the novel benzoylamino-benzopyran SB-220453. Cephalalgia 2000;20(6):546-53.
42. Bradley DP, Smith JM, Smith JM, Bockhorst KHJ, Papadakis NG, Hall LD, Parsons AA, James MF, Huang C-LH. Cortical spreading depression in the feline brain following sustained and transient stimuli studied using diffusion-weighted imaging. J Physiol 2002;544:39-56.
43. Lambert GA, Michalicek J. Cortical spreading depression reduces dural blood-flow-a possible mechanism for migraine pain. Cephalalgia 1994;14(6):430-6.
44. Lambert GA, Michalicek J, Storer RJ, Zagami AS. Effect of cortical spreading depression on activity of trigeminovascular sensory neurons. Cephalalgia 1999;19(7):631-8.
45. Kim DS, Duong TQ, Kim SG. High-resolution mapping of iso-orientation columns by fMRI. Nat Neurosci 2000;3(2):164-9.
46. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature 2001;412(6843):150-7.
47. Hardebo JEA. Cortical Excitatory Wave May Cause Both the Aura, and the Headache of Migraine. Cephalalgia 1992;12(2):75-80.
48. Colona DM, Meng W, Dead DD, Gowda M, Basija DW. Neuronal nitric oxide promotes cerebral cortical hyperaemia duirng SD in rabbits. Am J Physiol 1997;272:H1313-22.
49. Connor HE, Stubbs CM, Feniuk W, Humphrey PPA. Effect of sumatriptan, a selective 5-HT(1)-like receptor agonist, on pial vessel diameter in anesthetized cats. J Cerebral Blood Flow Metabol 1992;12(3):514-9.
50. Ferrari MD. Sumatriptan in the treatment of migraine. Neurol 1993;43(Suppl 3):S43-7.
51. Kobari M, Fukuuchi Y, Tomita M, Tanahashi N, Konno S, Takeda H. Effects of sumatriptan on the cerebral intraparenchymal microcirculation in the cat. Brit J Pharm 1993;110(4):1445-8.
52. 1B/1D[r] agonists: Insights into migraine pathophysiology using rizatriptan. Neurol 2000;55(9):S8-14.
53. Bateman DN. Triptans and migraine. Lancet 2000;355:860-1.
54. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral-artery dilatation-reversal by sumatriptan. Lancet 1991;338(8758):13-7.
55. Fowler PA, Lacey LF, Thomas M, Keene ON, Tanner RJN, Baber NS. The clinical-pharmacology, pharmacokinetics and metabolism of sumatriptan. Europe Neurol 1991;31(5):291-4.
56. Maassen VanDenBrink A, van den Broek RWM, de Vries R, Upton N, Parsons AA, Saxena PR. The potential anti-migraine compound SB-220453 does not contract human isolated blood vessels or myocardium; a comparison with sumatriptan. Cephalalgia 2000;20(6): 538-45.
57. 1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression. Brit J Pharmacol 1998;124(7):1345-54.
58. Maranhão-Filho PA, Martins-Ferreira H, Vincent MB. Sumatriptan blocks spreading depression in isolated chick retina. Cephalalgia 1997;17:822-5.
59. Herdon HJ, Jerman JC, Stean TO. Characterization of the binding of [3H]-SB-204269, a radiolabelled form of the new anticonvulsant SB-204269, to a novel binding site in rat brain membranes. Brit J Pharmacol 1997;121:1687-9.
60. Herdon HJ, Godfrey FM, Chan WN. Use of the radioligand [I-125]-SB-217644 in the characterisation and solubilisation of the novel binding site for the anticonvulsant SE-204269 in rat brain membranes and cell lines. Neuropharmacol 2000;39(12):2457-63.
61. Chan WN, Evans JM, Hadley MS, Herdon HJ, Jerman JC, Parsons AA, Read SJ, Stean TO, Thompson M, Upton N. Identification of (-)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2, 2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent. Bioorganic Med Chem Lett 1999;9(2):285-90.